OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

CLRB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cellectar Biosciences (CLRB) Earnings Date & Reports

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CLRB is expected to report earnings to fall 224.27% to -13 cents per share on August 18

Cellectar Biosciences CLRB Stock Earnings Reports

Q2'25

Est.

$-0.14

Q1'25

Beat

by $0.30

Q4'24

Beat

by $0.28

Q3'24

Missed

by $0.07

Q2'24

Missed

by $0.02

The last earnings report on May 13 showed earnings per share of 10 cents, beating the estimate of -18 cents. With 1.65M shares outstanding, the current market capitalization sits at 20.14M.

View a ticker or compare two or three

Compare

CLRB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CLRB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

100 Campus Drive

Phone

+1 608 441-8120

Employees

Web

https://www.cellectar.com